Title
Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis
Authoring Organization
Publication Month/Year
June 26, 2017
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
To develop recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP).
Inclusion Criteria
Female, Male, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Prevention, Treatment
Diseases/Conditions (MeSH)
D010024 - Osteoporosis, D005938 - Glucocorticoids
Keywords
glucocorticoids, glucocorticoid‐induced osteoporosis, GIOP
Source Citation
Buckley, L., Guyatt, G., Fink, H.A., Cannon, M., Grossman, J., Hansen, K.E., Humphrey, M.B., Lane, N.E., Magrey, M., Miller, M., Morrison, L., Rao, M., Byun Robinson, A., Saha, S., Wolver, S., Bannuru, R.R., Vaysbrot, E., Osani, M., Turgunbaev, M., Miller, A.S. and McAlindon, T. (2017), 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. Arthritis Care & Research, 69: 1095-1110. doi:10.1002/acr.23279